Clinical Performance of Plasma Metagenomic Sequencing in Immunocompromised Pediatric Patients
Journal of the Pediatric Infectious Diseases Society · 30.05.2024 · 13 (5) · 276-281
DOI: 10.1093/jpids/piae024 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 14.03.2024. Verfasst von Alice C Lehman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, University of Minnesota, Minneapolis, USA. Hauptthemen laut MEDLINE: Immunocompromised Host, Metagenomics. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, University of Minnesota Medical School.
Abstract (Originalsprache)
The performance of plasma metagenomic next-generation sequencing was evaluated in an immunocompromised pediatric population. The clinical impact was limited, with management changes in 13% of cases. Moreover, organisms thought to be non-pathogenic were commonly detected. Prospective studies in specific populations are required to clarify the utility of this emerging technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, University of Minnesota, Minneapolis, USA.
- Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, USA.
- University of Minnesota Medical School, Minneapolis, USA.
- Clinical and Translational Science Institute, University of Minnesota, Minneapolis, USA.
- Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, USA.
- Division of Stem Cell Transplantation and Children's Research Center, University Children's Hospital Zurich, University of Zürich, Zürich, Switzerland, and.
ORCID-Profile: Alice C Lehman, Daniel Drozdov, Beth K Thielen
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- University of Minnesota Medical School
- Medical Student Research
- University of Minnesota Foundation
- National Institute of Allergy and Infectious Diseases
- Centers for Disease Control and Prevention
- National Center for Advancing Translational Sciences
Zitieren
APA
Lehman, A. C., Goren, L. R., Evans, M. D., Toles, O., Drozdov, D., Andrews, S. L., McAllister, S. C., & Thielen, B. K. (2024). Clinical Performance of Plasma Metagenomic Sequencing in Immunocompromised Pediatric Patients. Journal of the Pediatric Infectious Diseases Society, 13(5), 276-281. https://doi.org/10.1093/jpids/piae024
Vancouver
Lehman AC, Goren LR, Evans MD, Toles O, Drozdov D, Andrews SL, et al. Clinical Performance of Plasma Metagenomic Sequencing in Immunocompromised Pediatric Patients. Journal of the Pediatric Infectious Diseases Society. 2024;13(5):276-281. doi:10.1093/jpids/piae024
BibTeX
@article{Lehman2024,
author = {Lehman, Alice C and Goren, Lea R and Evans, Michael D and Toles, Olivia and Drozdov, Daniel and Andrews, Shannon L and McAllister, Shane C and Thielen, Beth K},
title = {Clinical Performance of Plasma Metagenomic Sequencing in Immunocompromised Pediatric Patients},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2024},
volume = {13},
number = {5},
pages = {276--281},
doi = {10.1093/jpids/piae024}
}
EUVIMED